EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 238 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $134,000 | -20.7% | 2,695 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $169,000 | -72.2% | 2,695 | -58.9% | 0.00% | -80.0% |
| Q1 2021 | $608,000 | +520.4% | 6,551 | +337.3% | 0.01% | +400.0% |
| Q3 2018 | $98,000 | +30.7% | 1,498 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $75,000 | -3.8% | 1,498 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $78,000 | +13.0% | 1,498 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $69,000 | -96.7% | 1,498 | -97.1% | 0.00% | -95.7% |
| Q3 2017 | $2,079,000 | -53.3% | 51,400 | -60.9% | 0.02% | -59.6% |
| Q2 2017 | $4,455,000 | +465.4% | 131,400 | +425.6% | 0.06% | +375.0% |
| Q3 2016 | $788,000 | -75.0% | 25,000 | -77.7% | 0.01% | -75.0% |
| Q2 2016 | $3,157,000 | +7600.0% | 112,300 | +54949.0% | 0.05% | +4700.0% |
| Q1 2016 | $41,000 | – | 204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |